Chemical activators of RIM-BP3C can exert their influence through various intracellular signaling pathways leading to the activation of the protein. Forskolin, by activating adenylyl cyclase, can increase the concentration of cAMP within the cell. This rise in cAMP levels can then activate protein kinase A (PKA), which is known to phosphorylate target proteins, including RIM-BP3C, leading to its activation. Ionomycin, on the other hand, increases intracellular calcium levels, and this boost in calcium can activate calcium/calmodulin-dependent protein kinases, which can then target RIM-BP3C for phosphorylation and subsequent activation. Similarly, Thapsigargin can indirectly bring about the activation of RIM-BP3C by inhibiting the SERCA pump, thereby elevating intracellular calcium levels which in turn may activate kinases capable of phosphorylating RIM-BP3C.
Another chemical, Phorbol 12-myristate 13-acetate (PMA), can activate protein kinase C (PKC), and the activated PKC can phosphorylate RIM-BP3C, leading to its activation. Okadaic Acid and Calyculin A, as inhibitors of protein phosphatases 1 and 2A, prevent the dephosphorylation of proteins, which can cause a sustained phosphorylation state and activation of RIM-BP3C. Anisomycin activates stress-activated protein kinases that may also target RIM-BP3C for phosphorylation, thereby activating the protein. The Epidermal Growth Factor (EGF) stimulates the MAPK/ERK pathway, which is another route through which the phosphorylation and activation of RIM-BP3C can be achieved. Furthermore, Staurosporine and Bisindolylmaleimide I, although typically kinase inhibitors, can have off-target effects that result in the phosphorylation and activation of RIM-BP3C. Lastly, Dibutyryl-cAMP, a cAMP analog, can activate PKA and A23187, a calcium ionophore, can increase intracellular calcium, both of which may result in the activation of kinases that phosphorylate and activate RIM-BP3C. These diverse chemicals, through their unique mechanisms, all contribute to the phosphorylation state and activation of RIM-BP3C within cellular signaling pathways.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Activates adenylyl cyclase, increasing cAMP levels, which in turn activates PKA. PKA can phosphorylate and thus activate RIM-BP3C. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Increases intracellular calcium, which can activate calcium/calmodulin-dependent protein kinases that may phosphorylate RIM-BP3C. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activates PKC, which can lead to phosphorylation and activation of RIM-BP3C. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
Inhibits protein phosphatases 1 and 2A, resulting in sustained phosphorylation and activation of RIM-BP3C. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Inhibits the SERCA pump, increasing cytosolic calcium levels, which can activate kinases that phosphorylate and activate RIM-BP3C. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A sc-24000B sc-24000C | 10 µg 100 µg 500 µg 1 mg | $160.00 $750.00 $1400.00 $3000.00 | 59 | |
Inhibits protein phosphatases such as PP1 and PP2A, leading to increased phosphorylation and activation of RIM-BP3C. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Activates stress-activated protein kinases that may phosphorylate and thereby activate RIM-BP3C. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Although a kinase inhibitor, it can cause off-target kinase activation which may lead to activation of RIM-BP3C. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $103.00 $237.00 | 36 | |
Acts as a PKC inhibitor, but may lead to off-target effects that result in the activation of RIM-BP3C. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
A cAMP analog that activates PKA, potentially leading to phosphorylation and activation of RIM-BP3C. |